Related Experiment Video
Updated: Jun 21, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Differentiation-related gene-1 decreases Bim stability by proteasome-mediated degradation
Grazia Ambrosini1, Sharon L Seelman, Gary K Schwartz
1Department of Medicine, Laboratory of New Drug Development, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Abstract:
Drg1 was identified as a differentiation-related, putative metastatic suppressor gene in human colon and prostate cancer. Its expression is associated with resistance to irinotecan (CPT-11) therapy in preclinical colorectal cancer models both in vitro and in vivo. However, the functional significance of Drg1 in these processes is unknown. We have shown for the first time that Drg1 directly binds to the BH3-only proapoptotic protein Bim. Depletion of Drg1 by small interfering RNA induced up-regulation of Bim and its accumulation in the mitochondria, which correlated with loss of mitochondrial membrane potential and induction of apoptosis in cells exposed to SN-38. Further analyses revealed that Drg1 promotes degradation of Bim through the Cullin2/ElonginB-CIS ubiquitin-protein ligase complex. Conversely, in the absence of Drg1, Bim was stabilized and bound more abundantly to Hsp70. These results show that Drg1 renders cancer cells more resistant to chemotherapy through enhanced proteasome-mediated Bim degradation.
Insights
Drg1 suppresses chemotherapy resistance by promoting the degradation of the proapoptotic protein Bim. Loss of Drg1 leads to Bim accumulation, mitochondrial dysfunction, and apoptosis, impacting cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Drg1 is a differentiation-related gene implicated as a metastatic suppressor in colon and prostate cancer.
- Drg1 expression correlates with resistance to irinotecan (CPT-11) chemotherapy in colorectal cancer models.
- The precise functional role of Drg1 in these processes remains largely unelucidated.
Purpose of the Study:
- To investigate the functional significance of Drg1 in cancer cell response to chemotherapy.
- To elucidate the molecular mechanism by which Drg1 influences chemotherapy sensitivity.
Main Methods:
- Small interfering RNA (siRNA) was used to deplete Drg1 expression.
- Analysis of Bim protein levels, mitochondrial localization, and apoptosis induction.
- Investigation of the ubiquitin-protein ligase complex involved in Bim degradation.
Main Results:
- Drg1 directly binds to the proapoptotic protein Bim.
- Drg1 depletion leads to Bim upregulation, mitochondrial accumulation, and apoptosis.
- Drg1 facilitates Bim degradation via the Cullin2/ElonginB-CIS ubiquitin-protein ligase complex.
- Absence of Drg1 results in Bim stabilization and increased binding to Hsp70.
Conclusions:
- Drg1 confers cancer cell resistance to chemotherapy by enhancing proteasome-mediated Bim degradation.
- Targeting the Drg1-Bim interaction could represent a novel therapeutic strategy for overcoming chemotherapy resistance.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation
Regulation of Expression at Multiple Steps
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

